Skip to main content
NUTRITION 2025 Main banner

Late Breaking/Rapid Science Poster Session 1

(LB01-05-25) Long-Term Effect of Pancreaticojejunostomy in Patients With Chronic Pancreatitis

Saturday, May 31, 2025
11:45 AM - 12:45 PM ET
Location: Poster Board D-59

    Presenting Author(s)

  • Chong-Chi Chiu, MD (he/him/his)

    Professor
    Department of General Surgery, E-Da Cancer Hospital, I-Shou University, Kaohsiung, Taiwan
    Kaohsiung, Kaohsiung, Taiwan (Republic of China)

  • Chong-Chi Chiu, MD (he/him/his)

    Professor
    Department of General Surgery, E-Da Cancer Hospital, I-Shou University, Kaohsiung, Taiwan
    Kaohsiung, Kaohsiung, Taiwan (Republic of China)

    • Co-Author(s)

  • CT

    Chao-Jung Tsao, MD, PhD

    Chi Mei Medical Center, Liouying, Taiwan, Tainan, Taiwan (Republic of China)

  • CT

    Chao-Jung Tsao, MD, PhD

    Chi Mei Medical Center, Liouying, Taiwan, Tainan, Taiwan (Republic of China)

Disclosure(s):
Chong-Chi Chiu, MD: No relevant financial relationship(s) with ineligible companies to disclose.


Objectives: Chronic pancreatitis poses significant challenges in pain management, with pancreatic resection and decompression being key strategies. Among these, pancreaticojejunostomy (PJ) has emerged as a highly effective procedure, providing pain relief in most cases. This study delves into the long-term efficacy of PJ in alleviating pancreatic pain.

Methods: Between August 2020 and December 2024, a total of 31 patients with chronic pancreatitis underwent PJ due to severe, unmanageable pain have been reviewed. The mean age was 34±8 years; 27 were male, and four were female. The mean follow-up time was 3.9 years. We analyzed the information on alcohol consumption, pain intensity, and clinical signs of pancreatic dysfunction, laboratory data, radiologic characteristics, intra-operative findings, and outcomes. Histological exam confirmed chronic pancreatitis through pancreatic biopsy in all cases.

Results: The surgical intervention resulted in one operative mortality. Additionally, there were nine minor and three major complications. The overall pain relief rate following surgery was 83.9% (26/31), while 15 patients (48.4%) experienced recurrent chronic pancreatic pain during the follow-up period. Despite these challenges, the procedure demonstrated a favorable safety profile overall.

Conclusions: Pancreaticojejunostomy is a superior option for pain management in chronic pancreatitis, offering both effective pain relief and stable pancreatic function. This procedure is particularly noteworthy for its long-term benefits, making it a valuable treatment strategy for patients suffering from this debilitating condition.

Funding Sources: Nil